Northwestern Medicine, under the direction of Dr. William Catalona, was one of two health care providers to offer a new non-invasive blood test for prostate cancer. This new test, known as the Prostate Health Index (PHI), is three times as accurate as the standard PSA test.

Subscribe to Quest

"*" indicates required fields


This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*